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Background/aim: This study aimed to examine oral lichen planus (OLP) cases histopathologically and cytologically, describe different
clinical aspects of OLP manifestations, and associate different OLP clinical forms with self-reported oral health and with local and
systemic risk factors.
Materials and methods: All patients with a referral diagnosis of OLP received biopsies. The histological evaluation assessed infiltration
with lymphocytes, epithelial hyperplasia, and hyperkeratosis. Histology was used to validate the OLP diagnosis and to evaluate the
malignant transformation of OLP lesions. Clinical manifestations of OLP and potential local oral environment-related risks were
clinically assessed. Systemic risks were evaluated by a structured questionnaire.
Results: A total of 133 patients with a histologically confirmed OLP diagnosis were followed. There were more females (N = 109) than
males (N = 24) and the majority of patients were older than 50 years. The reticular form (45.1%) was the most prevalent clinical form
followed by the erosive-ulcerative form (33.8%). The histological characteristics were most pronounced in the erosive-ulcerative form.
Of the OLP cases, 2.3% had a malignant transformation.
Conclusion: Reticular and erosive-ulcerative were the most prevalent OLP forms. There were more female than male OLP patients.
Except for medication use, there were no statistically significant differences among different clinical OLP forms in either local or
systemic risk factor distributions.
Key words: Oral lichen planus, local risks, systemic risks, malignant transformation

1. Introduction
The World Health Organization has described oral lichen
planus (OLP) as a precancerous disease (1) that may involve
the mucous membrane and skin of various areas (2). A
predominance of OLP in women, commonly occurring in
the 6th and 7th decades of life, has been reported (3,4). The
prevalence of OLP in different populations ranges from
0.02% to 1.2% (5). The known clinical forms of OLP are
reticular, erosive-ulcerative, erythematous, and atrophic
(6), with the reticular and erosive-ulcerative forms being
the most common (7,8). OLP lesions are usually bilateral
and common oral sites are the buccal cheek mucosa,
tongue, gums, lips, and palate (9,10). Multiple sites of OLP
involvement are common (4,11).
A higher Candida presence in subjects with OLP
than in those with healthy mucosal tissues has been
reported (12). The prominent histological feature in OLP
is the hydropic degeneration of basal epithelial cells and
a band-like infiltration of T lymphocytes (13). A 27-year
* Correspondence: rasteniene.ruta@gmail.com
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retrospective study reported that the majority of OLP
cases (≥90%) presented infiltration of inflammatory cells
with a predominance of T lymphocytes and hyperkeratosis
or hyperorthokeratosis, while acanthosis and hyperplasia
were observed in one-third of the cases (11). The extent of
inflammation and clinical erythema has been associated
with the intensity of symptoms (8), i.e. minimally inflamed
OLP lesions were painless, whereas the most severe and
painful lesions were observed in patients with an erosiveulcerative OLP form (8,14,15).
The malignancy of OLP has been controversial with
malignant transformation rates ranging from 0.2% up to
12.5%, these rates being up to 60 times higher as compared
to the general population (13,16,17). The malignant
transformation of OLP lesions has been attributed to both
intrinsic (inflammation mediators) and extrinsic factors
(18). Risks of OLP, an exacerbation of this disease, or its
malignant potential have been associated with numerous
potential risk factors such as genetics, medication use,
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stress, dental treatments, systemic diseases, and lifestyle
factors such as smoking or alcohol abuse (19–23).
Patients with OLP or its risk factors have not been
studied in Lithuania; thus, it is unclear how OLP manifests
in Lithuanians compared to patients from other countries.
The aims of the present study were as follows:
• Examine OLP referral cases histopathologically
and cytologically.
• Evaluate clinical manifestations of OLP.
• Associate different OLP clinical forms with selfreported oral health, local, and systemic risk
factors.
2. Materials and methods
The present study was approved by the Research Ethics
Committee of the Faculty of Medicine of Vilnius University
and by the Ministry of Health of Lithuania. During the
4-year follow-up period, the clinical manifestations of
different OLP forms, potential local and systemic risk
factors for OLP, and the rate of malignant transformation
were studied.
2.1. Sample
The present study included all patients referred to the
Vilnius University Dental Clinic from different locations
around the country during the time period of 2009–2013
with a histologically confirmed lichen planus diagnosis.
Based on clinical manifestations, lichen planus cases
were grouped into papular, reticular, erosive-ulcerative,
bullous, or atrophic forms. The operationalization of study
variables is presented in Table 1.
2.2. Histological assessment
Incisional biopsy was used for histopathological
examinations and to confirm the diagnosis of lichen
planus. All patients with the referral diagnosis of OLP
received biopsies. The biopsy specimens ranged in size
from 3.0 mm × 3.0 mm to 10.0 mm × 2.0 mm. The biopsy
samples of the oral mucosa were 10% formalin-fixed,
paraffin-embedded, and stained with hematoxylin and
eosin and subsequently underwent morphological analysis
to evaluate oral mucosa infiltration with lymphocytes,
oral mucosa hyperplasia and hyperparakeratosis, and
ulceration of the squamous epithelium. The presence
of infiltration or hyperplasia was scored as minimal,
medium, or high. Histological assessment was also used to
validate the OLP diagnosis and to evaluate the malignant
transformation of OLP lesions to squamous cell carcinoma
2.3. Cytological assessment
In recent years, the importance of pathogenic
microorganisms such as Candida albicans in patients with
lichen planus has been recognized (24–27). Exfoliative
cytology concerning surface cells is used for identifying

the presence of abnormal cells, bacteria, and fungi. In
the present study, cytology samples were taken from the
tongue and a direct examination method was employed to
determine the presence of Candida species.
Two swabs were prepared and oral mucosa scrapings
were thinly spread and dried on a slide. One of the swabs
was fixed with a May–Grünwald fixer and the Nachtblau
method was used for staining. Subsequently, changes
of cell morphology (nucleus, cytoplasm, etc.) were
examined by a binocular microscope with an immersion
lens and eyepiece. Number and size of atypical cells, their
characteristics, degree of differentiation, mitosis quantity,
and nature were described. When cells with signs of
malignancy were found, an excisional biopsy specimen was
sent for histological examination and for the specification
of diagnosis to the National Center of Pathology.
The second swab was fixed with 96% ethanol and
positive Gram staining. This staining method was used
for the identification of microorganisms with a binocular
microscope. Using this staining, gram-positive microbial
cells, micelles and spores of Candida fungus, Actinomyces,
and cells of Lactarius turn blue, while gram-negative
microorganisms stain red.
2.4. Questionnaire/interview
Information regarding self-reported oral health and
systemic risk factors was collected by means of a
structured questionnaire. In order to reduce the number
of missing answers, personal interviews were added when
questionnaires were incomplete.
The self-administered questionnaire collected data about
demographics (sex, age), lifestyle (smoking, drinking),
number of negative life events, and information about
systemic risks such as family history of OLP, systemic
diseases, medication use, and extraoral manifestations of
OLP (skin and genitals).
2.5. Oral clinical examination
The clinical examination was performed by one examiner
(RA) and included an assessment of OLP clinical forms,
location of OLP lesions, and the presence of multiple sites
of oral involvement (Table 1).
2.6. Statistical analyses
All statistical analyses were performed employing SPSS
21.0. Bivariate analyses (chi-square test or Fisher exact
test) were used to compare proportions of cytological and
histological characteristics among different OLP forms.
Bivariate comparisons among different OLP forms were
also made regarding the mean number of local risks (refer
to Table 1: local risks) and regarding the mean number of
different systemic risk factors (refer to Table 1: systemic
risks). The threshold of statistical significance for all tests
was P < 0.05.
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Table 1. Operationalization of the study variables.
Study variables

Operationalization of variables

Histopathology

Leukocyte infiltration (1+, 2+, 3+), hyperkeratosis (present or absent), hyperplasia (1+, 2+, 3+), epithelial
necrosis (present or absent), carcinogenesis (present or absent).

Cytology

Presence of: bacteria (abundant or minimal), Candida (abundant, minimal, or absent), Actinomyces
(present or absent), and atypical cells (present or absent).
Biopsy-related side effects: (pain, bleeding, infection).
Clinical forms (examination): papular = 1, reticular = 2, erosive-ulcerative = 3, bullous = 4, atrophic = 5.

Clinical manifestation

Intraoral localization (examination): buccal mucosa, gums, tongue (lateral surfaces, back), lips (mucosa,
flushing), oral vestibule, palate (hard, soft), Yes = 1, No = 0. Multiple site involvement: total number of
OLP lesions.
Extraoral localization (self-reports): Skin: Yes = 1, No = 0. Genitals: Yes = 1, No = 0.
Exacerbation (self-reports): Yes = 1, No = 0.
Repeated OLP episodes (self-reports): Yes = 1, No = 0.

Local risks

Bimetallism (self-reports).
Local risk factors (examination): sharp tooth edges, poor oral hygiene, defective fillings, root tips, chronic
dental infections, dental caries, silver amalgams, fixed prostheses (crowns, bridges), and removable
prostheses.
Total number of systemic diseases (self-reports).

Systemic risks

Total number of medications (self-reports).
Total number of different allergies (self-reports).

Negative life events

Self-reported life events: partner’s death, death of a family member, divorce, financial or legal problems,
severe morbidity or trauma.

Family history

Family history (self-reports): Lichen Planus: Yes = 1, No= 0.
Family history (self-reports) of systemic diseases. Yes = 1, No = 0.

Lifestyle factors

Smoking (self-reports): Yes = 1, No = 0.
Alcohol abuse (self-reports): Yes = 1, No = 0.

3. Results
In the 4-year follow-up period, a total of 136 patients with
OLP diagnosis were referred to the Vilnius University
Žalgirio Clinic, of which 111 were females and 25 were
males. The majority of patients (~70.0%) were above 50
years of age. Of all referrals from different locations in the
country, only three cases were not histologically validated
for the OLP diagnosis. Thus, the study included a total of
133 OLP clinical cases.
3.1. Clinical, histopathological, and cytological
examinations
Figure 1 presents the distribution of different OLP clinical
forms, where one can see that the largest proportion of
patients presented with a reticular form (45.1%), followed
by an erosive-ulcerative form (33.8%) with the bullous
clinical form being the least prevalent (1.5%).
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Figure 1. Lichen planus – distribution of clinical forms.

The histological comparisons (Table 2) among different
OLP clinical forms revealed statistically significant
differences regarding all histological characteristics
except for the presence of malignant transformation. The
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6 (10.3)

2 (4.3)

0 (0.0)

4 (26.7)

--

P = 0.010

Papular, N = 11

Reticular, N = 58

Erosive-ulcerative, N = 47

Bullous, N = 2

Atrophic, N = 15

*Plaque-like

Significance#

--

8 (53.3)

1 (50.0)

19 (40.4)

34 (58.6)

9 (81.8)

N (%)

--

3 (20.0)

1 (50.0)

26 (55.3)

18 (31.1)

0 (0.0)

N (%)

P = 0.045

--

6 (40.0)

1 (50.0)

35 (74.5)

38 (65.5)

4 (36.4)

N (%)

--

9 (60.0)

1 (50.0)

12 (25.5)

20 (34.5)

7 (63.6)

N (%)

P < 0.001

--

13 (86.7)

0 (0.0)

11 (23.4)

25 (43.1)

7 (63.6)

N (%)

1+

Hyperplasia

--

0 (0.0)

1 (50.0)

31 (66.0)

26 (44.8)

4 (36.4)

N (%)

2+

* Plaque-like OLP (absent cases) was not included in statistical comparisons; # Chi-square test or Fisher exact test.

N (%)

Clinical forms

Absent

Present

3+

1+

2+

Hyperkeratosis

Leukocyte infiltration

Table 2. Histological assessment of oral lichen planus cases.

--

0 (0.0)

1 (50.0)

5 (10.6)

7 (12.1)

0 (0.0)

N (%)

3+

P < 0.001

--

7 (46.7)

2 (100.0)

36 (76.6)

10 (17.2)

0 (0.0)

N (%)

Present

--

8 (53.3)

0 (0.0)

11 (23.4)

48 (82.8)

11 (100.0)

N (%)

Absent

Epithelial necrosis

P = 0.230

--

0 (0.0)

0 (0.0)

3 (6.4)

0 (0.0)

0 (0.0)

N (%)

Present

Carcinoma

--

15 (100.0)

2 (100.0)

44 (93.6)

58 (100.0)

11 (100.0)

N (%)

Absent
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highest level of leukocyte infiltration and the presence of
hyperkeratosis, hyperplasia, and epithelial necrosis were
most frequently observed in erosive-ulcerative clinical
forms of OLP.
Table 3 presents results of cytological and clinical
examinations and compares four clinical OLP forms. The
bullous form had to be excluded from statistical analyses
because there were too few cases with a bullous clinical
OLP form (N = 2).
Histology of biopsy samples showed that different
clinical OLP forms presented a similar presence of bacteria
with about one-fourth of all clinical OLP forms presenting
extensive amounts of bacteria. The highest levels of
Candida species were found in the ulcerative-erosive OLP
cases. Only a few cases in all clinical OLP forms presented
with Actinomyces. The most exacerbation occurred in cases
with the ulcerative-erosive OLP clinical form and the least
number of repeated episodes were reported for patients

with the papular OLP form. The malignant transformation
rate for all clinical forms was 2.3%.
All clinical forms occurred in at least two sites and
there were no statistically significant differences in
mean numbers of site involvement among different
clinical forms. The largest proportion of extraoral lesion
involvement was reported for ulcerative-erosive OLP.
Statistically significant differences between the papular
and erosive-ulcerative forms (P < 0.001) and between the
papular and atrophic forms (P = 0.003) were found, with
better self-reported oral health observed in patients with
the papular OLP form than in patients with either erosiveulcerative or atrophic OLP forms. More details about the
interindividual variation in the four clinical OLP groups
are illustrated in box-whisker plots (Figures 2–4).
Figure 2 compares the clinical OLP forms in terms
of their acute manifestations. The bullous form is not
represented in this figure due to the limited number of

Table 3. Clinical and histological comparisons among OLP clinical forms.
Papular
N (%)

Reticular
N (%)

Erosive-ulcerative
N (%)

Atrophic
N (%)

P-values

Multiple bacteria

3 (27.3)

14 (23.3)

10 (22.2)

4 (26.7)

0.848

Extensive Candida

0 (0.0)

5 (8.3)

8 (17.8)

2 (13.3)

0.281

Actinomyces

0 (0.0)

2 (3.3)

1 (2.2)

0 (0.0)

0.825

Atypical cells

0 (0.0)

0 (0.0)

1 (2.2)

0 (0.0)

0.588

Exacerbation

0 (0.0)

0 (0.0)

33 (73.3)

2 (13.3)

<0.001

Repeated episodes

3 (27.3)

40 (66.7)

33 (73.3)

10 (66.7)

0.038

Buccal mucosa

8 (72.7)

56 (93.3)

37 (82.2)

13 (86.7)

0.170

Gums

6 (54.5)

27 (45.0)

26 (57.8)

2 (13.3)

0.026

Tongue

1 (9.1)

21 (35.0)

16 (35.6)

4 (26.7)

0.340

Lips

0 (0.0)

5 (8.3)

7 (15.6)

0 (0.0)

0.181

Oral vestibule

0 (0.0)

5 (8.3)

5 (11.1)

1 (6.7)

0.683

Palate

0 (0.0)

1 (1.7)

4 (8.9)

0 (0.0)

0.176

Extraoral

3 (27.3)

6 (10.0)

13 (28.9)

5 (33.3)

0.050

Mean ± SD

Mean ± SD

Mean ± SD

Mean ± SD

P-values

Multiple site involvement#

1.9 ± 0.7

2.5 ± 1.2

2.8 ± 1.6

2.3 ± 1.5

0.260

Self-reported oral health#

3.4 ± 0.8

2.8 ± 0.8

2.2 ± 0.7

2.3 ± 0.9

<0.001

Cytology*

Clinical manifestation*

Lesion localization*

* Chi-square test/Fischer exact test; # independent sample t-test.
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Figure 2. Exacerbation of different lichen planus forms.

Figure 3. Numbers of lichen planus lesions – comparison among
different clinical forms.

Figure 4. Self-rated oral health in patients with different OLP
clinical forms.

cases (N = 2). More of the erosive-ulcerative cases were
acute compared to the other three clinical forms (papular,
reticular, or atrophic).
Figure 3 presents the distribution of different clinical
forms of OLP in terms of the total number of clinical
sites of OLP lesions. One can see that all clinical forms
presented in at least two locations and the highest number
of sites with OLP lesions were observed for reticular and
ulcerative forms, with some patients having up to seven
intraoral lesions. Extraoral involvement (skin and genitals)
was self-reported in 22.0% of OLP cases.
As it relates to clinical symptoms, the majority of
patients with OLP noted at least some discomfort due
to their disease (95.0%), with 77.0% of them reporting
moderate and 54.0% reporting high levels of pain.
Figure 4 illustrates how patients with different OLP
forms perceived their oral health. The patients with erosiveulcerative or atrophic forms perceived their oral health as

being poorer (median: poor) than patients with other OLP
forms. There was substantial variation in self-rated oral
health among patients with all OLP clinical forms. Large
variation in self-rated oral health was observed among
the patients with papular OLP (from poor to excellent),
among the patients with the reticular form (from very
poor to good), and among the patients with the atrophic
form (from very poor to good).
3.2. Relationships between OLP clinical forms and local/
systemic risk factors
Table 4 presents a comparison of OLP clinical forms
regarding their potential risk factors. Both local and
systemic risks were related to different OLP clinical forms,
but only one significant association was found: patients
with atrophic OLP used more medications than patients
with other OLP clinical forms. The majority of OLP
patients had a family history of systemic diseases, while a
family history of lichen planus was rare.
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Table 4. Local and systemic risk comparisons among OLP clinical forms.
Number of

Papular
Mean±SD

Reticular
Mean±SD

Erosive-ulcerative
Mean±SD

Atrophic
Mean±SD

P-values

Local risks

2.5 ± 1.2

3.3 ± 1.5

3.5 ± 1.7

3.5 ± 2.8

0.301

Systemic diseases

2.0 ± 2.3

2.6 ± 2.1

3.2 ± 2.9

3.1 ± 1.4

0.348

Medications

0.9 ± 0.8

1.0 ± 1.0

1.0 ± 1.1

1.9 ± 1.1

0.025

Allergies

0.6 ± 0.7

0.6 ± 1.1

0.5 ± 0.7

0.3 ± 0.5

0.572

Negative events

1.8 ± 1.9

1.7 ± 1.2

1.5 ± 1.2

1.1 ± 1.1

0.291

No (%)

No (%)

No (%)

No (%)

Smoking

1 (9.1)

9 (15.0)

4 (8.9)

0 (0.0)

0.370

Alcohol abuse

0 (0.0)

2 (3.3)

0 (0.0)

1 (6.7)

0.409

Lichen planus

0 (0.0)

5 (8.3)

4 (8.9)

2 (13.3)

0.683

Systemic diseases

10 (91.9)

39 (75.0)

28 (63.2)

11 (73.3)

0.160

Family history

* Chi-square test/Fischer exact test; # independent sample t-test.

4. Discussion
The present study examined all patients referred to the
University Dental Clinic with a histologically confirmed OLP
diagnosis. There were significantly more females than males
and the majority of patients (~70.0%) were above 50 years of
age. Similar findings have been reported elsewhere (4).
Similar to other studies, the most commonly affected
site was the buccal mucosa, followed by the gums, and
multiple OLP lesions were observed in about half of
OLP patients (4). About half of our patients reported
substantial pain or discomfort related to their disease. This
finding is in accordance with other studies in which a high
proportion of OLP patients were symptomatic (2,28). We
observed patients with two or more sites affected by lichen
planus and extraoral involvement of lichen planus was
seen in approximately one out of five patients. Our rate of
extraoral involvement is similar to that of another study
(4), but lower than in other studies where rates of up to 45%
of extraoral involvement were reported (7,29,30). These
substantial differences between countries are difficult to
explain but we have no reason to assume that our patients
underreported their disease status. Given that exposure to
OLP risk factors might differ among countries, there may
also be differences regarding the rates of extraoral clinical
manifestations of this disease.
We examined associations between OLP and a number
of potential local as well as systemic risk factors. Except
for the relationship between the atrophic OLP form and
medication use, there were no statistically significant
differences in potential risk factor distributions among
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different OLP clinical forms. Possibly, potential risks
similarly contribute to the pathogenesis of different OLP
forms. Another explanation for our findings may be that,
due to a relatively low variation in some systemic risks,
we were not able to discern the associations between
different clinical forms of OLP and potential risk factors.
For example, only a small proportion of our OLP patients
reported smoking or alcohol abuse. Therefore, it is possible
that due to lack of variation in these risk factors, we were
unable to determine the effects of smoking or alcohol
abuse. It is important to note that evidence about the role
smoking or alcohol abuse plays in the etiopathogenesis
of lichen planus is inconsistent, with some studies not
associating these risks with OLP (4,31), while other studies
related smoking and alcohol abuse to a higher potential to
develop dysplastic changes (23).
In the present study, the malignant transformation rate
of 2.3% was slightly higher than in some studies where
this rate was under 2.0% (19,28,32). The rate of malignant
potential has been controversial, possibly due to a wide
range of reported incidences of 0%–12.5% (16,17). Further
studies are needed to better predict OLP patients who are at
risk of developing oral squamous cell carcinoma (OSCC).
It has been suggested that in patients with severe OLP,
determining the protooncogene C-MYC helps to predict
patients with a high risk of progression to oral squamous
cell carcinoma (33). Most importantly, OLP patients
are at increased risk for the development of OSCC, and
consequently regular follow-ups, e.g., once a year, are
necessary to detect any malignant transformation (19,32).
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Larger sample studies are needed to acquire evidence
about local as well as systemic risks and their relationship
to different OLP clinical forms. A case-control study with
well-matched matched controls, preferably recruited from
a general population, is recommended to study this rare
disease and its associated risks.
In conclusion, the reticular and ulcerative OLP forms
were more prevalent than the papular, atrophic, or bullous
clinical forms. More females than males were among our
OLP patients, and the majority of OLP patients were above
50 years of age. The most frequently affected sites were

the buccal mucosa and gums. There were no statistically
significant differences among OLP clinical forms in
distribution of local or systemic risk factors. About half
of the patients reported substantial discomfort or pain.
The rate of malignant transformation to squamous cell
carcinoma was 2.3%.
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